中东和非洲阿片类药物市场预测至 2030 年 - 区域分析 - 按产品（速释短效阿片类药物和缓释长效阿片类药物）、应用（疼痛管理、麻醉、腹泻抑制、咳嗽抑制、脱瘾等）、给药途径（口服、注射和透皮贴剂）和分销渠道（医院药房和零售药房）

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

No. of Pages: 84    |    Report Code: BMIRE00031007    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Opioids Market
Free Sample Buy Now
2022 年中东和非洲阿片类药物市场价值为 2.4922 亿美元，预计到 2030 年将达到 2.9979 亿美元；预计 2022 年至 2030 年的复合年增长率为 2.3%。

慢性疼痛发病率飙升促进中东和非洲阿片类药物市场发展

心血管疾病、癌症、肌肉骨骼疾病和神经血管疾病等慢性疾病会降低免疫力，严重影响人体健康。此外，许多患有这些疾病的患者都会经历慢性疼痛。上述疾病在成人和老年人群中最为常见。然而，这些疾病的病例在儿童中也明显增加。慢性疼痛在运动员、运动员和曾受过伤的人中也很常见。根据 NCBI（即美国国家生物技术信息中心）发表的一项研究，全球有 20% 的成年人患有疼痛，每年有 10% 的人新诊断出患有慢性疼痛。尽管疼痛影响所有人群，无论性别、种族/民族、收入、年龄或地理位置如何，但它在世界各地的分布并不均匀。处方阿片类药物，包括氢可酮、羟可酮和吗啡，是有效的止痛药，用于治疗由受伤、手术和癌症、关节炎等健康状况引起的疼痛。

根据国会研究服务处的数据，美国人可能会以更全面的疼痛疗法为代价获得更多的阿片类药物。阿片类药物处方行为的增加可以归因于保险报销计划，该计划鼓励人们使用阿片类药物而不是替代疼痛治疗，鼓励更有效护理的成本结构，以及将患者满意度与有效疼痛管理相结合的评估。因此，由于阿片类药物在疼痛管理方面的优势，慢性病患者的需求正在上升。

中东和非洲阿片类药物市场概览

中东和非洲的阿片类药物市场细分为南非、阿联酋、沙特阿拉伯和中东及非洲其他地区。在中东和非洲，阿片类药物用于缓解疼痛、姑息治疗和戒除阿片类药物成瘾。阿片类药物使用障碍的标准治疗方法包括使用美沙酮、丁丙诺啡或纳曲酮等药物进行治疗；这些用于治疗阿片类药物使用障碍 (MOUD) 的药物可减少阿片类药物过量死亡。2020 年，MOUD 仅在黎巴嫩、摩洛哥、伊朗和巴勒斯坦领土作为阿片类药物使用障碍的治疗方式提供。尽管该地区一些国家的经济和医疗保健发展不断加快，但中东和非洲的阿片类药物消费量增长有限。

中东和非洲阿片类药物市场收入及预测至 2030 年（百万美元）

中东和非洲阿片类药物市场细分

中东和非洲阿片类药物市场分为产品、应用、给药途径、分销渠道和国家。

根据产品，中东和非洲阿片类药物市场分为速释短效阿片类药物和缓释长效阿片类药物。速释短效阿片类药物部分在 2022 年占有较大的市场份额。速释短效阿片类药物进一步细分为羟可酮、氢可酮、曲马多、可待因、丙氧芬等。缓释长效阿片类药物进一步细分为羟可酮、芬太尼、吗啡、美沙酮等。

就应用而言，中东和非洲阿片类药物市场分为疼痛管理、麻醉、腹泻抑制、咳嗽抑制、脱瘾等。疼痛管理部分在 2022 年占据了最大的市场份额。

按给药途径，中东和非洲阿片类药物市场细分为口服、注射和透皮贴剂。口服部分在 2022 年占据了最大的市场份额。

按分销渠道，中东和非洲阿片类药物市场分为医院药房和零售药房。 2022 年，医院药房部门占据了更大的市场份额。

按国家/地区划分，中东和非洲阿片类药物市场分为沙特阿拉伯、南非、阿联酋和中东及非洲其他地区。2022 年，南非占据了中东和非洲阿片类药物市场份额的主导地位。

Neuraxpharm Pharmaceuticals SL、Endo International plc、Hikma Pharmaceuticals Plc、Mallinckrodt Plc、Rusan Pharma Ltd 和 Teva Pharmaceutical Industries Ltd 是中东和非洲阿片类药物市场的一些领先公司。

Middle East & Africa Opioids Strategic Insights

Strategic insights for Middle East & Africa Opioids involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-opioids-market-strategic-framework.webp
Get more information on this report

Middle East & Africa Opioids Report Scope

Report Attribute Details
Market size in 2022 US$ 249.22 Million
Market Size by 2030 US$ 299.79 Million
Global CAGR (2022 - 2030) 2.3%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 产品
  • 速释短效阿片类药物
  • 缓释长效阿片类药物
By 应用
  • 疼痛管理
  • 麻醉
  • 止泻
  • 止咳
  • 戒毒
By 给药途径
  • 口服
  • 注射
  • 透皮贴剂
By 分销渠道
  • 医院药房
  • 零售药房
Regions and Countries Covered 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Neuraxpharm Pharmaceuticals SL
  • Endo International plc
  • Hikma Pharmaceuticals Plc
  • Mallinckrodt Plc
  • Rusan Pharma Ltd
  • Teva Pharmaceutical Industries Ltd
    		•
    Get more information on this report

    Middle East & Africa Opioids Regional Insights

    The regional scope of Middle East & Africa Opioids refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/middle-east-and-africa-opioids-market-geography.webp
    Get more information on this report
    Identical Market Reports with other Region/Countries

    The List of Companies - Middle East & Africa Opioids Market

    1. Neuraxpharm Pharmaceuticals SL
    2. Endo International plc
    3. Hikma Pharmaceuticals Plc
    4. Mallinckrodt Plc
    5. Rusan Pharma Ltd
    6. Teva Pharmaceutical Industries Ltd
    Frequently Asked Questions
    How big is the Middle East & Africa Opioids Market?

    The Middle East & Africa Opioids Market is valued at US$ 249.22 Million in 2022, it is projected to reach US$ 299.79 Million by 2030.

    What is the CAGR for Middle East & Africa Opioids Market by (2022 - 2030)?

    As per our report Middle East & Africa Opioids Market, the market size is valued at US$ 249.22 Million in 2022, projecting it to reach US$ 299.79 Million by 2030. This translates to a CAGR of approximately 2.3% during the forecast period.

    What segments are covered in this report?

    The Middle East & Africa Opioids Market report typically cover these key segments-

  • 产品 (速释短效阿片类药物, 缓释长效阿片类药物)
  • 应用 (疼痛管理, 麻醉, 止泻, 止咳, 戒毒)
  • 给药途径 (口服, 注射, 透皮贴剂)

    • What is the historic period, base year, and forecast period taken for Middle East & Africa Opioids Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Opioids Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
    • Who are the major players in Middle East & Africa Opioids Market?

    The Middle East & Africa Opioids Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Neuraxpharm Pharmaceuticals SL
  • Endo International plc
  • Hikma Pharmaceuticals Plc
  • Mallinckrodt Plc
  • Rusan Pharma Ltd
  • Teva Pharmaceutical Industries Ltd
    • Who should buy this report?

    The Middle East & Africa Opioids Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East & Africa Opioids Market value chain can benefit from the information contained in a comprehensive market report.

    middle-east-and-africa-opioids-market